Mirae Asset Global Investments Co., Ltd.

Position in GHRS — GH Research PLC

CIK 1569395 SEOUL, M5

Position in GHRS

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$82,467

+$36,983 QoQ

Shares Held

3,068

-5.2% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#48

of 62 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Mirae Asset Global Investments Co., Ltd. holds $279,047,947 across 206 Biotechnology names. GHRS ranks #101 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	210,209	$104,417,115
2	REGN	Regeneron Pharmaceuticals, Inc.	93,632	$58,383,296
3	ALNY	Alnylam Pharmaceuticals, Inc.	61,531	$18,522,675
4	MDGL	Madrigal Pharmaceuticals, Inc.	33,420	$17,944,868
5	ARGX	Argenx SE	11,164	$10,357,623
6	ONC	BeOne Medicines Ltd.	33,808	$9,634,265
7	RPRX	Royalty Pharma plc	150,556	$8,441,674
8	INCY	Incyte Corp	63,812	$7,233,728

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$82,467	3,068	-5.2%	Shares	Sole	2026-07-22
2026-03-31	$45,484	3,235	+7.3%	Shares	Sole	2026-05-04
2025-12-31	$38,277	3,014	-97.2%	Shares	Sole	2026-01-26
2023-12-31	$616,905	106,363	+14.6%	Shares	Defined	2024-01-24
2023-09-30	$932,479	92,784	+16.2%	Shares	Defined	2023-10-26
2023-06-30	$947,693	79,873	-18.4%	Shares	Defined	2023-08-10
2023-03-31	$782,005	97,873	-7.5%	Shares	Defined	2023-05-04
2022-12-31	$1,027,967	105,758	-16.0%	Shares	Defined	2023-02-09
2022-09-30	$1,463,248	125,925	-20.8%	Shares	Defined	2022-11-10
2022-06-30	$1,586,829	159,001	+16.4%	Shares	Defined	2022-08-15
2022-03-31	$2,498,578	136,609	+0.6%	Shares	Defined	2022-05-10
2021-12-31	$3,168,214	135,800	—	Shares	Defined	2022-02-08
No filing history on record for this holder in this stock.